EMA, AMA and African regulatory authorities join forces on Ebola outbreak response

Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of authorisation: 26/08/2013, Revision: 21, Status: Authorised

EMA’s API general terms and conditions of use - Terms of use

Medicines for human use under evaluation

Updates to industry contact management for authorisation products (IRIS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 June 2026, 11:00 (CEST) to 11 June 2026, 12:15 (CEST)

Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures European Commission final decision, 26/03/2026, 29/05/2026, 02/06/2026

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 39, Status: Authorised